Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07449676

Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression

Background: Mental disorders are recognized as a major cause of disability and disease burden across the lifespan. Gua Sha is believed to improve mental health and sleep quality significantly. Tui Jing is an innovative type of Gua Sha therapy that penetrates deep into the muscles and fascia rather than just acting on the surface of the skin. Modern research has revealed that Gua Sha is extensively utilized for pain-related symptoms, and its therapeutic effects may be attributed to anti-inflammatory and immunomodulatory mechanisms. Although Gua Sha has demonstrated efficacy in treating various diseases, limited research exists regarding its impact and underlying mechanisms on mental health. This study will conduct a clinical trial to assess the efficacy of Tuijing Therapy on mental health. Autonomic function is closely associated with psychological symptoms, and HRV reflects the activation of the vagus nerve. This study aims to obtain preliminary evidence that Gua Sha can modulate HRV by regulating vagal function, potentially ameliorating psychological disorders. Population: The sample size is estimated using G*power, and a total of 64 participants are needed. Adults without any chronic diseases who score over 14 on the HAM-D 17 and have no smoking or drinking habits will be included. Method: A randomized controlled study will be conducted with Tuijing therapy as the intervention and sham therapy as the control. The intervention group will receive the actual intervention, while the sham intervention group will undergo a sham ultrasound treatment process that does not involve the active therapeutic components. A computer-generated random allocation schedule will be compiled before commencement by a researcher not involved in recruiting participants. Tuijing therapy will be administered as arm A, while the sham control group will serve as arm B. There will be a 5-day interval between interventions. Participants in arm B will receive 4 sessions of sham ultrasound therapy, with 45 minutes for 1 month. Participants in arm A will receive 4 sessions of Tui Jing therapy for 45 minutes for 1 month. Heart rate variability, brain activity, skin reflection, pain perception, psychological symptoms, and sleep quality will be assessed as outcome measures. Outcomes: The primary outcomes of this study are the efficacy of Tui Jing therapy on depressive symptoms. As secondary outcomes, this study will assess changes in heart rate variability, brain activity, skin reflection, stress and anxiety symptoms, and sleep quality. Heart rate variability will be measured using a heart rate variability monitoring device, and brain activity will be measured by fNIRS. Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). Stress and anxiety symptoms will be evaluated using the Depression Anxiety Stress Scales (DASS).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Hong Kong Polytechnic University

Hong Kong, Hung Hom

Location status: Recruiting

Location contact

Zoey Yutong Li

CONTACT

[email protected]

About this study

Procedures: The researcher will conduct an initial telephone interview to provide study information and screen potential participants for eligibility. Each participant will receive full details about the study's purpose and will be required to sign an informed consent form. All participants will be invited to two in-person sessions before accepting any intervention. In the first session, comprehensive medical histories, brief semi-structured interviews for psychological symptoms, clinical examinations, general information, and questionnaires will be conducted to determine eligibility. Eligible participants in the first session will be included in the second session. The second session will be scheduled to collect baseline data for further analysis. Eligible participants who meet the inclusion criteria will be randomly assigned to receive either Tui Jing therapy or sham stimulation. The intervention will be conducted by a qualified therapist (Registered Chinese Medicine Practitioner in Hong Kong) from the Department of Rehabilitation Sciences at PolyU, while another qualified researcher will be responsible for clinical interviews, screening, and data collection.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 - 55 years old
  • Willingness to participate in the study and undergo randomization
  • Proficiency in Chinese
  • Absence of severe chronic diseases
  • Experience with depressive symptoms for over three months
  • Scoring 20 or higher on the Montreal Cognitive Assessment (MoCA)
  • Scoring above 14 on the Hamilton Depression Rating Scale 17

Exclusion criteria

  • The presence of cardiovascular disease (CVD)
  • Severe head trauma, intracranial hypertension, implanted ferromagnetic devices, or a history of epilepsy
  • Engagement in any pharmacological or non-pharmacological treatments within the past month
  • Existing skin conditions or susceptibility to skin injuries
  • Any form of cognitive impairment

Treatment and study plan

manual therapy: Tui Jing therapy

Other

(Gua Sha + Meridian pressure) was utilized, a specialized form of Gua Sha that incorporates traditional techniques with targeted pressure on specific meridians.

sham ultrasound intervention

Device

Participants will receive a sham ultrasound intervention on the same meridians. To enhance comfort and prevent cold sensations from the metal probe, the ultrasound device will be pre-warmed to body temperature. A gel, mimicking the texture of the lubricant used in Tui Jing therapy, will be applied. The device will mimic the motion, direction, duration, and frequency of the Tui Jing therapy, but without activating the ultrasound's therapeutic mode. The participants will be informed that they are accepting low-intensity ultrasound mode, which will not produce any sensory perception, ensuring in distinguishing ability between active and sham interventions

Primary outcomes

  1. Psychological outcomes - Depression symptoms

    Time frame: through study completion, an average of 12 months

    Hamilton Depression Rating Scale (HAMD-17) Scale Range: 0-52 points Interpretation: Higher scores indicate greater depression severity Assessment: Semi-structured interview by trained raters Time Frame: Baseline, post-intervention, and two-week follow-up.

  2. Psychological outcomes - Depression symptoms

    Time frame: through study completion, an average of 12 months

    Patient Health Questionnaire (PHQ-9) Scale Range: 0-27 points Interpretation: Higher scores indicate greater depression severity Assessment: Self-administered questionnaire

Secondary outcomes

  1. Sleep quality

    Time frame: From the date of randomization until two weeks after the last treatment

    Pittsburgh Sleep Quality Index (PSQI) Scale Range: 0-21 points Interpretation: Higher scores indicate poorer sleep quality Assessment: Standardized self-report questionnaire

  2. Psychological outcomes - stress and anxiety

    Time frame: From the date of randomization until two weeks after the last treatment

    The Depression Anxiety Stress Scale (DASS) is a set of self-report questionnaires designed to measure the severity of negative emotional symptoms.

    Scale Range: 0-63 points. Interpretation: Higher scores indicate greater symptom severity. Anxiety: Normal (0-7), Mild (8-9), Moderate (10-14), Severe (15-19), Extremely Severe (20+).

    Stress: Normal (0-14), Mild (15-18), Moderate (19-25), Severe (26-33), Extremely Severe (34+)

  3. Sleep Efficiency

    Time frame: From the date of randomization until two weeks after the last treatment

    Objective Sleep Efficiency Measurement: (Total sleep time / Time in bed) × 100% Unit: Percentage (%). Tool: Fitbit Inspire 2 (FDA-cleared wearable device). Data Collection: Automated daily sync to the research platform.

  4. Subjective Sleep Quality and duration

    Time frame: From the date of randomization until two weeks after the last treatment

    Measurement: 10-point Likert scale (1 = "Very Poor", 10 = "Excellent") Unit: Scale score (1-10) Measurement: self-report sleep duration Tool: Standardized sleep diary

  5. Heart Rate Variability (HRV)

    Time frame: through study completion, an average of 12 months

    Metrics: RMSSD (Root Mean Square of Successive Differences), SDNN (Standard Deviation of NN Intervals), Low Frequency (LF: 0.04-0.15 Hz), High Frequency (HF: 0.15-0.40 Hz). Unit: Milliseconds (ms) Tool: NeXus-10 Biofeedback System (Mind Media) Protocol: 5-minute pre and post resting-state measurement; Task measurement (Cognitive neuroscience around 17 min); Synchronous measurement during intervention.

  6. Skin Reactions

    Time frame: through study completion, an average of 12 months

    Skin Discoloration Severity Measurement Protocol: Capture multispectral images using the IBOOLO DE-4100 system. Calculate the ΔContrast between affected and normal skin areas. Formula: ΔContrast = |Mean lesion chroma value - Mean normal skin chroma value|.

    Unit: Standardized chroma difference (0-100; 0=no difference, 100=maximal difference). Dimensionless relative units (a.u.) or standardized relative changes will be used. Quality Control: Imaging environment: Standardized D65 lighting, Analysis software: IBOOLO SkinAnalyzer Pro v3.2

  7. Brain activity

    Time frame: through study completion, an average of 12 months

    Brain activity measurement: Human brain mapping using the NIRSport 2, a functional near-infrared spectroscopy (fNIRS) platform, is used to measure cerebral hemodynamics using a non-invasive method. This detection is determined by two types of near-infrared wavelength spectroscopy (NIRS). By reflecting near-infrared light off the cerebral tissue, information on tissue oxygenation and metabolism can be obtained. Tools : Specifications:

    • Measurements: changes in oxyhemoglobin and deoxyhemoglobin concentration
    • Light source: high-powered dual LEDs
    • Wavelengths: 760 nm and 850 nm
    • Number of emitters: 16
    • Number of detectors: 16
    • Fiber holder configurations: freely configurable based on the 10-20 system The unit of fNIRS measurement results is the change in molar concentration, expressed as (micromoles/liter/mm).

    Protocol: 5-minute pre and post resting-state measurement; Task measurement (Cognitive neuroscience around 17 min); Synchronous measurement during intervention.

Study contacts

Contact information is provided by the study sponsor or research team.

Yutong Li

CONTACT

[email protected]

852 61917986

Sponsors and collaborators

Lead sponsor

The Hong Kong Polytechnic University

Other

Registry information

Official study title

Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression: A Randomized Controlled Study

Acronym: TJ

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Mar 4, 2026
Registry last updated
Mar 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.